Literature DB >> 16763549

Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling.

Yasunori Shintani1, Seiji Takashima, Yoshihiro Asano, Hisakazu Kato, Yulin Liao, Satoru Yamazaki, Osamu Tsukamoto, Osamu Seguchi, Hiroyuki Yamamoto, Tomi Fukushima, Kazuyuki Sugahara, Masafumi Kitakaze, Masatsugu Hori.   

Abstract

Neuropilin-1 (NRP1) is a co-receptor for vascular endothelial growth factor (VEGF) that enhances the angiogenic signals cooperatively with VEGFR2. VEGF signaling is essential for physiological and pathological angiogenesis through its effects on vascular endothelial cells (ECs) and smooth muscle cells (SMCs), but the mechanisms coordinating this response are not well understood. Here we show that a substantial fraction of NRP1 is proteoglycan modified with either heparan sulfate or chondroitin sulfate on a single conserved Ser. The composition of the NRP1 glycosaminoglycan (GAG) chains differs between ECs and SMCs. Glycosylation increased VEGF binding in both cell types, but the differential GAG composition of NRP1 mediates opposite responsiveness to VEGF in ECs and SMCs. Finally, NRP1 expression and its GAG modification post-transcriptionally regulate VEGFR2 protein expression. These findings indicate that GAG modification of NRP1 plays a critical role in modulating VEGF signaling, and may provide new insights into physiological and pathological angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763549      PMCID: PMC1500974          DOI: 10.1038/sj.emboj.7601188

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  37 in total

Review 1.  Heparan sulfate: growth control with a restricted sequence menu.

Authors:  J T Gallagher
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 2.  Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor.

Authors:  I Zachary
Journal:  Am J Physiol Cell Physiol       Date:  2001-06       Impact factor: 4.249

3.  Vascular endothelial growth factor-dependent down-regulation of Flk-1/KDR involves Cbl-mediated ubiquitination. Consequences on nitric oxide production from endothelial cells.

Authors:  Martine Duval; Sara Bédard-Goulet; Chantal Delisle; Jean-Philippe Gratton
Journal:  J Biol Chem       Date:  2003-03-19       Impact factor: 5.157

4.  Expression of vascular endothelial growth factor receptors in smooth muscle cells.

Authors:  A Ishida; J Murray; Y Saito; C Kanthou; O Benzakour; M Shibuya; E S Wijelath
Journal:  J Cell Physiol       Date:  2001-09       Impact factor: 6.384

5.  Functional expression of murine V2R pheromone receptors involves selective association with the M10 and M1 families of MHC class Ib molecules.

Authors:  Jennifer Loconto; Fabio Papes; Ernie Chang; Lisa Stowers; Elsy P Jones; Toyoyuki Takada; Attila Kumánovics; Kirsten Fischer Lindahl; Catherine Dulac
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

6.  Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain.

Authors:  Roni Mamluk; Ze'ev Gechtman; Matthew E Kutcher; Nijole Gasiunas; John Gallagher; Michael Klagsbrun
Journal:  J Biol Chem       Date:  2002-05-01       Impact factor: 5.157

7.  The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1.

Authors:  G Fuh; K C Garcia; A M de Vos
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

8.  VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding.

Authors:  Shay Soker; Hua-Quan Miao; Masashi Nomi; Seiji Takashima; Michael Klagsbrun
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

9.  Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis.

Authors:  Seiji Takashima; Masafumi Kitakaze; Masanori Asakura; Hiroshi Asanuma; Shoji Sanada; Fumi Tashiro; Hitoshi Niwa; Jun-ichi Miyazaki Ji; Seiichi Hirota; Yukihiko Kitamura; Takashi Kitsukawa; Hajime Fujisawa; Michael Klagsbrun; Masatsugu Hori
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

10.  VEGF: a modifier of the del22q11 (DiGeorge) syndrome?

Authors:  Ingeborg Stalmans; Diether Lambrechts; Frederik De Smet; Sandra Jansen; Jian Wang; Sunit Maity; Paige Kneer; Maren von der Ohe; Ann Swillen; Christa Maes; Marc Gewillig; Daniel G M Molin; Peter Hellings; Thurid Boetel; Maartin Haardt; Veerle Compernolle; Mieke Dewerchin; Stephane Plaisance; Robert Vlietinck; Beverly Emanuel; Adriana C Gittenberger-de Groot; Peter Scambler; Bernice Morrow; Deborah A Driscol; Lieve Moons; Camila V Esguerra; Geert Carmeliet; Annett Behn-Krappa; Koen Devriendt; Désiré Collen; Simon J Conway; Peter Carmeliet
Journal:  Nat Med       Date:  2003-01-21       Impact factor: 53.440

View more
  69 in total

1.  Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment.

Authors:  Usman Yaqoob; Sheng Cao; Uday Shergill; Kumaravelu Jagavelu; Zhimin Geng; Meng Yin; Thiago M de Assuncao; Ying Cao; Anna Szabolcs; Snorri Thorgeirsson; Martin Schwartz; Ju Dong Yang; Richard Ehman; Lewis Roberts; Debabrata Mukhopadhyay; Vijay H Shah
Journal:  Cancer Res       Date:  2012-06-27       Impact factor: 12.701

Review 2.  Signal transduction by vascular endothelial growth factor receptors.

Authors:  Sina Koch; Lena Claesson-Welsh
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 3.  Neuropilin Functions as an Essential Cell Surface Receptor.

Authors:  Hou-Fu Guo; Craig W Vander Kooi
Journal:  J Biol Chem       Date:  2015-10-08       Impact factor: 5.157

Review 4.  Proteoglycan signaling co-receptors: roles in cell adhesion, migration and invasion.

Authors:  Karthikeyan Mythreye; Gerard C Blobe
Journal:  Cell Signal       Date:  2009-05-08       Impact factor: 4.315

Review 5.  An introduction to proteoglycans and their localization.

Authors:  John R Couchman; Csilla A Pataki
Journal:  J Histochem Cytochem       Date:  2012-09-26       Impact factor: 2.479

6.  Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding.

Authors:  Gerdy B ten Dam; Els M A van de Westerlo; Anurag Purushothaman; Radu V Stan; Johan Bulten; Fred C G J Sweep; Leon F Massuger; Kazuyuki Sugahara; Toin H van Kuppevelt
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

7.  Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization.

Authors:  Harukiyo Kawamura; Xiujuan Li; Katsutoshi Goishi; Laurens A van Meeteren; Lars Jakobsson; Stéphanie Cébe-Suarez; Akio Shimizu; Dan Edholm; Kurt Ballmer-Hofer; Lena Kjellén; Michael Klagsbrun; Lena Claesson-Welsh
Journal:  Blood       Date:  2008-07-29       Impact factor: 22.113

8.  Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients.

Authors:  Ricardo Saban; Marcia R Saban; Julie Maier; Ben Fowler; Mark Tengowski; Carole A Davis; Xue-Ru Wu; Daniel J Culkin; Paul Hauser; Joseph Backer; Robert E Hurst
Journal:  Am J Physiol Renal Physiol       Date:  2008-09-24

9.  Thematic review series: sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a.

Authors:  Purna Mukherjee; Anthony C Faber; Laura M Shelton; Rena C Baek; Thomas C Chiles; Thomas N Seyfried
Journal:  J Lipid Res       Date:  2008-02-20       Impact factor: 5.922

10.  Uteroplacental insufficiency affects kidney VEGF expression in a model of IUGR with compensatory glomerular hypertrophy and hypertension.

Authors:  Mariana Baserga; Allyson L Bares; Merica A Hale; Christopher W Callaway; Robert A McKnight; Pascale H Lane; Robert H Lane
Journal:  Early Hum Dev       Date:  2009-02-01       Impact factor: 2.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.